Diarrheagenic Escherichia coli in human immunodeficiency virus (HIV) pediatric patients in Lima, Peru

Am J Trop Med Hyg. 2010 Jul;83(1):158-63. doi: 10.4269/ajtmh.2010.09-0596.

Abstract

We conducted a prospective study in three hospitals in Lima in human immunodeficiency virus (HIV) children to determine the frequency of diarrheagenic Escherichia coli. Five E. coli colonies/patients were studied by a multiplex real-time polymerase chain reaction to identify the six currently recognized groups of diarrhea-associated E. coli. We have analyzed 70 HIV-associated diarrheal and 70 control samples from HIV-infected children without diarrhea. Among the diarrheal episodes 19% were persistent, 3% dysenteric, and 33% were associated with moderate or severe dehydration. The diarrheagenic E. coli were the most commonly isolated pathogens in diarrhea (19%) and control samples (26%) (P = 0.42), including enteroaggregative (6% versus 10%), enteropathogenic (6% versus 10%), and enterotoxigenic E. coli (4% versus 3%), respectively. The HIV-infected children with diarrhea had the worse age-related immunosuppression, higher viral loads, and were on highly active antiretroviral treatment (HAART) less often than HIV-infected children without diarrhea. Diarrheagenic E. coli were highly resistant to ampicillin (74%) and cotrimoxazole (70%).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology*
  • Age Distribution
  • Antiretroviral Therapy, Highly Active
  • Child
  • Enterotoxigenic Escherichia coli*
  • Escherichia coli Infections / etiology*
  • Escherichia coli Infections / genetics
  • Female
  • HIV Infections / complications*
  • HIV Infections / genetics
  • HIV*
  • Humans
  • Male
  • Peru / epidemiology
  • Prospective Studies
  • Virulence Factors

Substances

  • Virulence Factors